MT1-MMP Activation of TGF-? Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|16|7|618-630

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.7, 2016-08, pp. : 618-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Activation of &bgr;1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer

By  

Current Cancer Drug Targets, Vol. 14, Iss. 5, 2014-06 ,pp. : 446-457

Bentham Science Publishers

Access to resources Recommend Favorite

The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer

By  

Current Drug Targets, Vol. 11, Iss. 4, 2010-01 ,pp. : 474-481

Bentham Science Publishers

Access to resources Recommend Favorite

Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signaling and switching on miR-200b

By Gao Xue-Jun   Liu Jian-Wei   Zhang Qing-Guang   Zhang Jing-Jing   Xu Hai-Tao   Liu Hong-Jian  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 4, 2015-04 ,pp. : 256-262

Govi-Verlag

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1881-1890

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer

By  

Current Drug Targets, Vol. 13, Iss. 13, 2012-12 ,pp. : 1649-1653

Bentham Science Publishers

Access to resources Recommend Favorite